Columbia University, Naomi Berrie Diabetes Center — New York, New York

Columbia University, Naomi Berrie Diabetes Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Columbia University, Naomi Berrie Diabetes Center has participated in 2 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus, New-onset Type 1 Diabetes Mellitus, T1DM.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University, Naomi Berrie Diabetes Center?

Columbia University, Naomi Berrie Diabetes Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University, Naomi Berrie Diabetes Center conducted?

Columbia University, Naomi Berrie Diabetes Center has 2 clinical trials on record. Their work covers Type 1 Diabetes Mellitus, New-onset Type 1 Diabetes Mellitus, T1DM.

Is Columbia University, Naomi Berrie Diabetes Center accredited by Crixeo Health?

Columbia University, Naomi Berrie Diabetes Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University, Naomi Berrie Diabetes Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.